CS
WST icon

Candriam SCA’s West Pharmaceutical WST Stock Holding History

Candriam SCA’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$34.6M Buy
96,349
+87,225
+956% +$26.7M 0.16% 136
2026
Q1 		$2.29M Sell
9,124
-753
-8% -$187K 0.01% 498
2025
Q4 		$2.72M Buy
9,877
+4,847
+96% +$1.33M 0.01% 460
2025
Q3 		$1.32M Sell
5,030
-740
-13% -$180K 0.01% 549
2025
Q2 		$1.26M Sell
5,770
-543
-9% -$116K 0.01% 571
2025
Q1 		$1.41M Sell
6,313
-662
-9% -$182K 0.01% 544
2024
Q4 		$2.28M Buy
6,975
+823
+13% +$259K 0.01% 487
2024
Q3 		$1.85M Buy
6,152
+434
+8% +$133K 0.01% 511
2024
Q2 		$1.88M Sell
5,718
-4,850
-46% -$1.71M 0.01% 496
2024
Q1 		$4.18M Buy
10,568
+5,167
+96% +$1.91M 0.03% 371
2023
Q4 		$1.9M Buy
5,401
+1,250
+30% +$442K 0.01% 502
2023
Q3 		$1.55M Hold
4,151
– – 0.01% 485
2023
Q2 		$1.59M Sell
4,151
-6,422
-61% -$2.29M 0.01% 539
2023
Q1 		$3.37M Sell
10,573
-13,483
-56% -$3.94M 0.02% 458
2022
Q4 		$5.66M Sell
24,056
-1,449
-6% -$343K 0.04% 360
2022
Q3 		$6.28M Sell
25,505
-31,798
-55% -$9.69M 0.04% 347
2022
Q2 		$17.3M Sell
57,303
-303
-0.5% -$98.6K 0.14% 156
2022
Q1 		$23.7M Sell
57,606
-2,833
-5% -$1.11M 0.16% 142
2021
Q4 		$28.3M Buy
60,439
+6,571
+12% +$2.83M 0.18% 134
2021
Q3 		$22.9M Sell
53,868
-14,891
-22% -$6.28M 0.16% 154
2021
Q2 		$24.7M Buy
68,759
+44,139
+179% +$14.6M 0.17% 148
2021
Q1 		$6.7M Hold
24,620
– – 0.06% 322
2020
Q4 		$6.97M Sell
24,620
-1,037
-4% -$291K 0.06% 330
2020
Q3 		$7.05M Sell
25,657
-5,439
-17% -$1.44M 0.07% 293
2020
Q2 		$7.06M Buy
+31,096
New +$6.11M 0.07% 276

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Candriam SCA's WST Position: Q2 2026 in Review

Candriam SCA increased its West Pharmaceutical (WST) stake by 956% in Q2 2026, buying an estimated $26.7M and bringing the position to 96,349 shares worth $34.6M. The position accounts for 0.16% of the portfolio, ranked #136.

Candriam SCA first reported a position in WST in Q2 2020 and has held it in 25 quarters since. 831 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Candriam SCA held 96,349 shares of West Pharmaceutical worth $34.6M as of Q2 2026.
  • Candriam SCA bought 87,225 West Pharmaceutical shares in Q2 2026, an estimated $26.7M.
  • West Pharmaceutical made up 0.16% of Candriam SCA's portfolio in Q2 2026, its #136 holding.
  • Candriam SCA first reported a position in West Pharmaceutical in Q2 2020 and has held it in 25 quarters since.
  • 831 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Candriam SCA's 13F filing for Q2 2026, filed 13 Aug 2026.